STOCK TITAN

FOXO Technologies Inc. - $FOXO STOCK NEWS

Welcome to our dedicated page for FOXO Technologies news (Ticker: $FOXO), a resource for investors and traders seeking the latest updates and insights on FOXO Technologies stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FOXO Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FOXO Technologies's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.74%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.74%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.74%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.6%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
59.24%
Tags
none
FOXO Technologies Inc.

NYSE:FOXO

FOXO Rankings

FOXO Stock Data

3.56M
4.46M
35.97%
4.16%
4.06%
Software Publishers
Information
Link
United States of America
MINNEAPOLIS

About FOXO

formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.